Cardiovascular conditions
Together with Sanquin Research (Amsterdam, the Netherlands) Okklo has developed novel cyclodextrin derivatives for the treatment or prevention of bleeding in anticoagulant use or blood clotting disorders.
This asset is now further developed by Alveron Pharma.